Atara Biotherapeutics Inc. (AT20) - Analysis

opens in 3d 3h 57m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,059.58 0.12%
EUR/USD 1.15 0.09%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.05%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,059.58 0.12%
EUR/USD 1.15 0.09%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.05%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,059.58 0.12%
EUR/USD 1.15 0.09%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.05%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,059.58 0.12%
EUR/USD 1.15 0.09%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.58 -0.05%
XPT/USD 1,003.20 0.33%

8.79750 EUR

0

0%

Last update Apr 2, 9:56 PM CEST

Market closed

Day range

8.79750

8.79750

8.79750

Previous close

8.79750

Open

8.79750

Access this stock data via API

Atara Biotherapeutics Inc.

8.80

0

0%

Analysis

Analyst ratings

Firm	Date	Action
Freedom Broker	Jan 21, 2026	Downgrade
Canaccord Genuity	Jan 13, 2026	Downgrade
Canaccord Genuity	Dec 19, 2025	Maintains
Canaccord Genuity	Mar 11, 2025	Maintains
HC Wainwright & Co.	Jan 22, 2025	Reiterates
Canaccord Genuity	Jan 17, 2025	Maintains
Rodman & Renshaw	Dec 20, 2024	Initiates
Canaccord Genuity	Nov 13, 2024	Maintains
HC Wainwright & Co.	Aug 21, 2024	Reiterates
Mizuho	Aug 16, 2024	Upgrade
Canaccord Genuity	Aug 13, 2024	Maintains
Goldman Sachs	Jul 17, 2024	Maintains

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.